Articles dans des revues avec comité de lecture (112)
33.
Wolking, S., Moreau, C., Nies, A. A., Schaeffeler, E., McCormack, M., Auce, P., Avbersek, A., Becker, F., Krenn, M., Møller, R. S., Nikanorova, M., Weber, Y. Y., Weckhuysen, S., Cavalleri, G., Delanty, N., Depondt, C., Johnson, M., Koeleman, B., Kunz, W. W., Marson, A. G., Sander, L. J., Sills, G., Striano, P., Zara, F., Zimprich, F., Schwab, M., Krause, R., Sisodiya, S., Cossette, P., Girard, S. S., & Lerche, H. (2020). Testing association of rare genetic variants with resistance to three common antiseizure medications. Epilepsia, 61(4), 657-666. doi:10.1111/epi.1646734.
Wolking, S., Schulz, H., Nies, A. A., McCormack, M., Schaeffeler, E., Auce, P., Avbersek, A., Becker, F., Klein, K. M., Krenn, M., Møller, R. S., Nikanorova, M., Weckhuysen, S., Consortium, E. P., Cavalleri, G., Delanty, N., Depondt, C., Johnson, M., Koeleman, B., Kunz, W. W., Marson, A. G., Sander, J. W., Sills, G., Striano, P., Zara, F., Zimprich, F., Weber, Y. Y., Krause, R., Sisodiya, S., Schwab, M., Sander, T., & Lerche, H. (2020). Pharmacoresponse in genetic generalized epilepsy: a genome-wide association study. Pharmacogenomics, 21(5), 325-335. doi:10.2217/pgs-2019-017936.
Thorpe, J., Ashby, S., Hallab, A., Ding, D., Andraus, M., Dugan, P., Perucca, P., Costello, D., French, J. J., O'Brien, T. J., Depondt, C., Andrade, D., Sengupta, R., Delanty, N., Jette, N., Newton, C. C., Brodie, M. J., Devinsky, O. I., Helen Cross, J., Sander, J. W., Hanna, J., & Sen, A. (2020). Evaluating risk to people with epilepsy during the COVID-19 pandemic: Preliminary findings from the COV-E study. Epilepsy & behavior., 107658. doi:10.1016/j.yebeh.2020.10765839.
Silvennoinen, K., Depondt, C., Brodie, M. J., Chinthapalli, K., de Haan, G. J., Doherty, C. P., Heavin, S., McCormack, M., Petrovski, S., Sargsyan, N., Slattery, L., & Willis, J. (2019). Comparative effectiveness of antiepileptic drugs in juvenile myoclonic epilepsy. Epilepsia Open, 4(3), 420-430. doi:10.1002/epi4.1234940.
Heavin, S., McCormack, M., Wolking, S., Slattery, L., Walley, N., Avbersek, A., Novy, J., Sinha, S. S., Radtke, R., Doherty, C. P., Auce, P., Craig, J., Johnson, M., Koeleman, B., Krause, R., Kunz, W. W., Marson, A. G., O'Brien, T. J., Sander, J. W., Sills, G., Stefansson, H., Striano, P., Zara, F., Depondt, C., Sisodiya, S., Goldstein, D., Lerche, H., Cavalleri, G., & Delanty, N. (2019). Genomic and clinical predictors of lacosamide response in refractory epilepsies. Epilepsia Open. doi:10.1002/epi4.1236043.
Berghuis, B., Stapleton, C., Sonsma, A. A., Hulst, J., de Haan, G. J., Lindhout, D., Demurtas, R., Krause, R., Depondt, C., Kunz, W. W., Zara, F., Striano, P., Craig, J., Auce, P., Marson, A. G., Stefansson, H., O'Brien, T. J., Johnson, M., Sills, G., Wolking, S., Lerche, H., Sisodiya, S., Sander, L. J., Cavalleri, G., Koeleman, B. B., & McCormack, M. (2019). A genome-wide association study of sodium levels and drug metabolism in an epilepsy cohort treated with carbamazepine and oxcarbazepine. Epilepsia Open, 4(1), 102-109. doi:10.1002/epi4.12297